New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and 12 assays ...

New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays ...

TORONTO and SAN FRANCISCO, March 17, 2026 /PRNewswire/ - Dalriada Drug Discovery ("Dalriada"), a partnered discovery organization supporting small-molecule programs from hit identification through ...

New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays ...

ACR-368, a CHK1/2 inhibitor in a registrational-intent Phase 2b study, showed potent preclinical synergy with Topoisomerase 1 (Topo 1) ...

ACR-368, a CHK1/2 inhibitor in a registrational-intent Phase 2b study, showed potent preclinical synergy with Topoisomerase 1 ...

Researchers at the Josep Carreras Leukaemia Research Institute propose a new view of cancer based on spatial hallmark ...

A single-cell RNA atlas maps sea urchin development, revealing rare neuronal lineages and gene activity across stages, and ...

Shares of Bruker Corporation (NASDAQ:BRKR) and 10x Genomics (NASDAQ:TXG) declined Monday after Microsoft’s CEO tweeted about GigaTIME, an AI model developed by Microsoft, Providence Health, and the ...

Researchers discovered immune cell aggregates in the gut may signal blood vessel cells and fibroblasts to produce excess ...

Chronos- PD shows that biological changes associated with Parkinson's disease (PD) can emerge up to 12 years before clinical diagnosisUncovered reproducible early molecular signals and distinct molecu ...

A metabolic enzyme studied for over seven decades has a hidden second function - it can unwind RNA and promote cell cycle ...